SCHOLAR ROCK HLDG CORP's ticker is SRRK and the CUSIP is 80706P103. A total of 87 filers reported holding SCHOLAR ROCK HLDG CORP in Q1 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,931,270 | -3.1% | 553,700 | +3.0% | 0.02% | +4.3% |
| Q2 2023 | $4,054,997 | -8.5% | 537,798 | -2.9% | 0.02% | -23.3% |
| Q1 2023 | $4,429,600 | -11.6% | 553,700 | 0.0% | 0.03% | +30.4% |
| Q4 2022 | $5,010,985 | +30.6% | 553,700 | 0.0% | 0.02% | 0.0% |
| Q3 2022 | $3,837,000 | +24.3% | 553,700 | -1.5% | 0.02% | -52.1% |
| Q2 2022 | $3,086,000 | +699.5% | 562,182 | +3647.9% | 0.05% | +1100.0% |
| Q3 2018 | $386,000 | +65.0% | 15,000 | 0.0% | 0.00% | +100.0% |
| Q2 2018 | $234,000 | – | 15,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 2,450,000 | $31,581,000 | 1.32% |
| Logos Global Management LP | 675,000 | $8,701,000 | 1.13% |
| Samsara BioCapital, LLC | 339,611 | $4,378,000 | 1.10% |
| Redmile Group, LLC | 2,407,326 | $31,030,000 | 0.97% |
| Bellevue Group AG | 2,184,425 | $28,157,000 | 0.33% |
| Frazier Life Sciences Management, L.P. | 156,000 | $2,011,000 | 0.17% |
| Atom Investors LP | 25,839 | $333,000 | 0.16% |
| GSA CAPITAL PARTNERS LLP | 32,010 | $413,000 | 0.06% |
| Tekla Capital Management LLC | 108,833 | $1,403,000 | 0.05% |
| Virtus ETF Advisers LLC | 6,212 | $80,000 | 0.04% |